Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis : meta-analysis of six initial trials and five long-term extensions

スポンサーリンク

概要

• 論文の詳細を見る
• 2010-06-01

著者

• Nishimoto Norihiro

  Wakayama Medical University

• ITO Kyoko

  Chugai Pharmaceutical Co., Ltd.

• TAKAGI Nobuhiro

  Laboratory of Immune Regulation, Wakayama Medical University

• Takagi Nobuhiro

  Laboratory Of Immune Regulation Wakayama Medical University

• Ito Kyoko

  Chugai Pharmaceutical Co. Ltd.

関連論文

• A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs
• Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI) : significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition
• Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis : meta-analysis of six initial trials and five long-term extensions
• Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiograp
• Diagnostic features of mild cellulitis phlegmon in patients with rheumatoid arthritis treated with tocilizumab : a report of two cases

スポンサーリンク